Author
Listed:
- Piotr Merks
(Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University, 01-938 Warsaw, Poland
Department of Pharmaceutical Technology, Faculty of Pharmacy, Collegium, Medicum in Bydgoszcz, 85-089 Bydgoszcz, Poland)
- Urszula Religioni
(Collegium of Business Administration, Warsaw School of Economics, 02-513 Warsaw, Poland)
- Krzysztof Bilmin
(Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University, 01-938 Warsaw, Poland)
- Jedrzej Lewicki
(Polish Pharmaceutical Group, 91-342 Łódź, Poland)
- Marta Jakubowska
(Polish Pharmaceutical Group, 91-342 Łódź, Poland)
- Anna Waksmundzka-Walczuk
(Solec Hospital, 00-382 Warsaw, Poland)
- Aleksandra Czerw
(Department of Economics and Medical Law, Medical University of Warsaw, 00-791 Warsaw, Poland
Department of Economic and System Analysis, National Institute of Public Health-National Institute of Hygiene, 00-791 Warsaw, Poland)
- Agnieszka Barańska
(Department of Computer Science and Medical Statistics with the Studio of Remote Learning, Medical University of Lublin, 20-954 Lublin, Poland)
- Joanna Bogusz
(Department of Epidemiology, National Institute of Public Health-National Institute of Hygiene, 00-791 Warsaw, Poland)
- Katarzyna Plagens-Rotman
(Hipolit Cegielski State University of Applied Sciences, 62-200 Gniezno, Poland)
- Dariusz Świetlik
(Department of Biostatistics and Neural Networks, Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland)
- Ewelina Drelich
(Department of Pharmaceutical Technology, Faculty of Pharmacy, Collegium, Medicum in Bydgoszcz, 85-089 Bydgoszcz, Poland
Polish Pharmaceutical Group, 91-342 Łódź, Poland)
- Damian Świeczkowski
(First Department of Cardiology, Medical University of Gdansk, Debinki 7, 80-211 Gdansk, Poland)
- Jane Lambert
(Emergency Care Gateway (ECG), Milton Keynes MK13 9AP, UK)
- Miłosz Jaguszewski
(Polish Pharmaceutical Group, 91-342 Łódź, Poland
First Department of Cardiology, Medical University of Gdansk, Debinki 7, 80-211 Gdansk, Poland)
- Grzegorz Juszczyk
(Department of Public Health, Medical University of Warsaw, 02-097 Warsaw, Poland
National Institute of Public Health-National Institute of Hygiene, 00-791 Warsaw, Poland)
- Bander Balkhi
(Medication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh 4545, Saudi Arabia
College of Pharmacy-Department of Clinical Pharmacy, King Saud University, Riyadh 4545, Saudi Arabia)
- Regis Vaillancourt
(Children’s Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada)
Abstract
Background: Immunization rates among the adult population in Poland are below desired targets, urging the need to expand this service in the community. During the COVID-19 pandemic, the ultimate goals for limiting the spread of the infection are vaccines against SARS-CoV-2. Pharmaceutical companies are in a race for the fastest possible way to deliver vaccines. Community pharmacists in Poland are recognised as an accessible yet underutilised group of medical professionals. Therefore, involving pharmacists in vaccinations may have beneficial results for the healthcare system. Objectives: The objectives of this study were to assess the readiness and willingness of community pharmacists following the Pharmacist Without Borders project who had either been trained or not in providing immunization services, and to identify the factors that may support the implementation of such services in Poland. Methods: This study was conducted among pharmacists between February and August 2020 in Poland. A survey was developed to determine their readiness to provide vaccination services in their pharmacies, to recognise any barriers to vaccinations, as well as the factors necessary to implement vaccination services in Polish pharmacies. Results: A total of 1777 pharmacists participated in the study, comprising 127 (7.1%) pharmacists trained in vaccinations during the Pharmacists Without Borders project and 1650 (92.9%) pharmacists not participating in the workshops. Pharmacists participating in the workshops more often indicated that providing vaccinations in community pharmacies would improve the overall vaccination rate ( p = 0.0001), and that pharmacists could play an important role in advertising and promoting vaccinations ( p = 0.0001). For the pharmacists not participating in the workshops, they indicated to a much greater extent possible barriers affecting the readiness to provide vaccinations in pharmacies. They most often pointed out that vaccination services would result in a significant workload increase ( p = 0.0001), that pharmacies were not adapted to immunization, and that there were not enough training courses for pharmacists ( p = 0.0001). Conclusion: The pharmacists working in community pharmacies indicated many advantages of vaccinations in pharmacies. This study identified barriers to the introduction of vaccinations and factors necessary to implement these services in pharmacies. The pharmacists trained during the immunization programme of the Pharmacists Without Borders project showed a greater readiness to provide immunization services.
Suggested Citation
Piotr Merks & Urszula Religioni & Krzysztof Bilmin & Jedrzej Lewicki & Marta Jakubowska & Anna Waksmundzka-Walczuk & Aleksandra Czerw & Agnieszka Barańska & Joanna Bogusz & Katarzyna Plagens-Rotman & , 2021.
"Readiness and Willingness to Provide Immunization Services after Pilot Vaccination Training: A Survey among Community Pharmacists Trained and Not Trained in Immunization during the COVID-19 Pandemic i,"
IJERPH, MDPI, vol. 18(2), pages 1-15, January.
Handle:
RePEc:gam:jijerp:v:18:y:2021:i:2:p:599-:d:479158
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Anna Kowalczuk & Alexandre Wong & Kevin Chung & Urszula Religioni & Dariusz Świetlik & Katarzyna Plagens-Rotman & Jameason D. Cameron & Agnieszka Neumann-Podczaska & Katarina Fehir Šola & Justyna Kazm, 2022.
"Patient Perceptions on Receiving Vaccination Services through Community Pharmacies,"
IJERPH, MDPI, vol. 19(5), pages 1-8, February.
- Steliana Ghibu & Anca Maria Juncan & Luca Liviu Rus & Adina Frum & Carmen Maximiliana Dobrea & Adriana Aurelia Chiş & Felicia Gabriela Gligor & Claudiu Morgovan, 2021.
"The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic,"
IJERPH, MDPI, vol. 18(18), pages 1-20, September.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:2:p:599-:d:479158. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.